Singapore markets closed

Rocket Pharmaceuticals, Inc. (RCKT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
23.47+0.70 (+3.07%)
At close: 04:00PM EDT
23.47 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
186,342
186,342
165,570
125,476
105,438
Selling general and administrative
73,317
73,317
58,773
41,772
28,865
Total operating expenses
259,659
259,659
223,843
166,248
134,303
Operating income or loss
-259,659
-259,659
-223,843
-166,248
-134,303
Interest expense
1,875
1,875
1,909
5,889
7,547
Total other income/expenses net
-
-
-
-
-580
Income before tax
-245,595
-245,595
-221,863
-169,069
-139,700
Income from continuing operations
-245,595
-245,595
-221,863
-169,069
-139,700
Net income
-245,595
-245,595
-221,863
-169,069
-139,700
Net income available to common shareholders
-245,595
-245,595
-221,863
-169,069
-139,700
Basic EPS
-3.19
-2.92
-3.26
-2.67
-2.52
Diluted EPS
-3.19
-2.92
-3.26
-2.67
-2.52
Basic average shares
79,743
84,009
68,149
63,235
55,381
Diluted average shares
79,743
84,009
68,149
63,235
55,381